Latest Financial Results
Q2 2024
Quarter Ended Jun 30, 2024
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2023
Report Links
Email Alerts
Receive updates straight into your inbox
Company Overview
HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company that is dedicated to transforming cardiac care through the power of personalized insights. The company’s proprietary vectorelectrocardiography (VECG) technology collects 3D signals of the heart’s electrical activity and converts them into a 12-lead ECG. This platform technology is designed to be used on portable, patient-friendly devices such as a credit-card sized monitor, watch or patch. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining how cardiac health is managed in the future.
View Management Team View Board of DirectorsInvestor Contact Information
Company
HeartBeam, Inc.
2118 Walsh Avenue
Suite 210
Santa Clara, CA 95050
T: 408-899-4443
Investor Relations
MZ North America
Chris Tyson
Executive Vice President
T: 949-491-8235
BEAT@mzgroup.us
Transfer Agent
VStock Transfer
18 Lafayette Place
Woodmere, NY 11598